Back to User profile » Dr Wei Peng
Papers published by Dr Wei Peng:
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
Chen X, Xing J, Zhang B, Peng W, Huang Z, Zhu T, Liu L, Liu X, Wan X, Mao Y, Chang X, Zhou K, Pan J, Hu D, Tan H, Zhang Y, Guan M, Du S
Journal of Hepatocellular Carcinoma 2025, 12:2379-2391
Published Date: 21 October 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S
Journal of Hepatocellular Carcinoma 2025, 12:561-577
Published Date: 19 March 2025
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Tang X, Chen J, Peng W, Yang Z, Hu L, Ye Z, Fu Y, Hu D, Zhou Z, Chen M, Zhang Y, Wang JC
ImmunoTargets and Therapy 2024, 13:559-569
Published Date: 26 October 2024
Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study
Wang J, Zheng Z, Wu T, Li W, Wang J, Pan Y, Peng W, Hu D, Hou J, Xu L, Zhang Y, Chen M, Zhang R, Zhou Z
Journal of Hepatocellular Carcinoma 2022, 9:999-1010
Published Date: 14 September 2022